Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease

被引:105
作者
Caviness, J. N.
Hentz, J. G.
Evidente, V. G.
Driver-Dunckley, E.
Samanta, J.
Mahant, P.
Connor, D. J.
Sabbagh, M. N.
Shill, H. A.
Adler, C. H.
机构
[1] Mayo Clin, Dept Neurol, Scottsdale, AZ USA
[2] Mayo Clin, Biostat Sect, Scottsdale, AZ USA
[3] Banner Good Samaritan Hlth Ctr, Phoenix, AZ USA
[4] Sun Hlth Res Inst, Sun City, AZ USA
关键词
Parkinson's disease; EEG; dementia; mild cognitive impairment;
D O I
10.1016/j.parkreldis.2007.01.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We sought to define quantitative electroencephalographic (EEG) measures as biomarkers of both early and late cognitive decline in Parkinson's disease (PD). PD subjects classified as cognitively normal (PD-CogNL), mild cognitive impairment (PD-MCI), and dementia (PD-D) were studied. Cognitive status and neuropsychological testing was correlated with background rhythm and frequency band EEG power across five frequency bands. We conclude that global EEG measures have potential use as biomarkers in the study of both early and late cognitive deterioration in PD, including for evaluating its treatment. PD-MCI has mean quantitative EEG characteristics that represent an intermediate electrophysiological state between PD-CogNL and PD-D. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:348 / 354
页数:7
相关论文
共 38 条
[1]   Motor impairment in normal aging, clinically possible Parkinson's disease, and clinically probable Parkinson's disease: longitudinal evaluation of a cohort of prospective brain donors [J].
Adler, CH ;
Hentz, JG ;
Joyce, JN ;
Beach, T ;
Caviness, JN .
PARKINSONISM & RELATED DISORDERS, 2002, 9 (02) :103-110
[2]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[3]   Parkinson disease neuropathology - Later-developing dementia and loss of the levodopa response [J].
Apaydin, H ;
Ahlskog, JE ;
Parisi, JE ;
Boeve, BF ;
Dickson, DW .
ARCHIVES OF NEUROLOGY, 2002, 59 (01) :102-112
[4]   Cognitive status correlates with neuropathologic stage in Parkinson disease [J].
Braak, H ;
Rüb, U ;
Steur, ENHJ ;
Del Tredici, K ;
de Vos, RAI .
NEUROLOGY, 2005, 64 (08) :1404-1410
[5]  
BUZSAKI G, 1988, J NEUROSCI, V8, P4007
[6]   Abnormal corticomuscular coherence is associated with the small amplitude cortical myoclonus in Parkinson's disease [J].
Caviness, JN ;
Adler, CH ;
Sabbagh, MN ;
Connor, DJ ;
Hernandez, JL ;
Lagerlund, TD .
MOVEMENT DISORDERS, 2003, 18 (10) :1157-1162
[7]   Small-amplitude cortical myoclonus in Parkinson's disease: Physiology and clinical observations [J].
Caviness, JN ;
Adler, CH ;
Beach, TG ;
Wetjen, KL ;
Caselli, RJ .
MOVEMENT DISORDERS, 2002, 17 (04) :657-662
[8]  
Driver-Dunckley ED, 2005, NEUROLOGY, V64, pA201
[9]   What causes mental dysfunction in Parkinson's disease? [J].
Emre, M .
MOVEMENT DISORDERS, 2003, 18 :S63-S71
[10]  
Fahn S, 1987, Recent Dev. Park. Dis, P153